Prevention of Silent Cerebral Thromboembolism by Oral Anticoagulation With Dabigatran After Pulmonary Vein Isolation for Atrial Fibrillation

Clinical trial NCT02067182 · COMPLETED

Trial details

NCT number: NCT02067182
Sponsor: Georg Nickenig
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Atrial Fibrillation Cardioembolic Events Oral Anticoagulation

Start date: 2015-08-01
Primary completion: 2020-09-15
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.